Hims & Hers Health, Inc.

Day range

$27.98 – $29.26

Open

$28.64

Prev close

$29.13

Volume

8.47M

Market cap

$6.8B

Shares out

224.94M

P/E

—

P/S

2.64

P/B

20.97

P/FCF

91.30

ROE

-43.8%

ROA

-3.9%

Debt/Equity

4.21

Div yield

0.00%

As of Oct 22, 2026

• Executive leadershipOct 7, 2026

  In connection with Mr. Franklin's employment as chief accounting officer and his appointment as principal accounting officer, Mr. Franklin will receive (i) an annual base salary of $425,000, (ii) a signing bonus of $150,000... and (iii) a grant of restricted stock units... with a grant value of $3,000,000... Mr. Franklin will also be eligible for an annual discretionary bonus with a target of 50% of his Base Salary.

• Executive leadershipJul 17, 2026

  On July 13, 2026, Irene Becklund informed Hims & Hers Health, Inc. (the "Company") of her intention to resign as Chief Accounting Officer and Principal Accounting Officer, effective as of October 9, 2026. Ms. Becklund has indicated to the Company that her resignation is not the result of any dispute or disagreement with the Company's accounting principles or practices or financial statements and disclosures.

• Debt activityJul 1, 2026

  On July 1, 2026, XeCare LLC and Apostrophe Pharmacy LLC (collectively, the "Sellers"), subsidiaries of Hims & Hers Health, Inc. (the "Company"), entered into a Master Receivables Purchase Agreement (the "RPA") with JPMorgan Chase Bank, N.A., as purchaser... The RPA includes a $400,000,000 facility limit for eligible receivables and is subject to customary covenants, representations and warranties, events of default and termination provisions for facilities of this type.

• Shareholder meetingsJun 15, 2026

  On June 11, 2026, Hims & Hers Health, Inc. (the "Company") held its Annual Meeting of Stockholders (the "Annual Meeting"). At the Annual Meeting, the Company's stockholders voted on three proposals... The tabulation of the stockholders' votes on each proposal brought before the Annual Meeting is as follows: Proposal 1: The election of nine directors... Proposal 2: The ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm... Proposal 3: Advisory approval of the Company's executive compensation.

• Debt activityJun 2, 2026

  On May 29, 2026, Hims & Hers Health, Inc. (the "Company"), as borrower, entered into Amendment No. 3 (the "Amendment") to the Revolving Credit and Guaranty Agreement, dated as of February 18, 2025... The Amendment, among other things, (a) amends certain provisions of the Credit Agreement to facilitate the closing of the Company's acquisition of EUC Management Pty Ltd ACN 631 013 860 (d/b/a Eucalyptus) ("Eucalyptus"), including providing a grace period for the Company to comply with the covenants and representations and warranties under the Credit Agreement as a result of such acquisition; (b) establishes joinder obligations for material foreign subsidiaries; (c) increases downstream investment capacity in non-loan party subsidiaries.

Days to cover

5.3

Short interest

54.77M

Avg volume

10.41M

As of Sep 30, 2026 · reported to FINRA twice monthly.

• Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
  negativeGlobeNewswire Inc.· Oct 22, 2026
• Hims & Hers Health, Inc. Securities Fraud Class Action Result of Deceptive Privacy and Billing Practices and Over 14% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC
  negativeGlobeNewswire Inc.· Oct 20, 2026
• Bragar Eagel & Squire, P.C. Reminds Hims & Hers Health, Inc. Investors of the Upcoming Lead Plaintiff Deadline and Urges Investors to Contact the Firm Before November 2nd
  negativeGlobeNewswire Inc.· Oct 20, 2026
• Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
  negativeGlobeNewswire Inc.· Oct 19, 2026
• Hims Is Reaching the Three Million Member Milestone
  positiveThe Motley Fool· Oct 19, 2026